2016Unpublished venueRequires access

Effect of knocking down miR-19a on proliferation and apoptosis of human glioma cell line U251 in vitro

Ruibing Du

Open publisher page 0 citations

Abstract

Objective To investigate the effect of knocking down miR -19a on proliferation and apoptosis of human glioma cell line U251 in vitro. Methods U251 cells were cultured routinely. MiR-19a inhibitor was transfected into U251 cells by Lipofectamine 2000. At the same time, the negative control group and blank control group were established. The expression level of miR-19a was detected by RT-PCR. and cell proliferation was analyzed by CCK-8 assay. The changes of cell apoptosis and cycle were monitored by flow cytometry. Results Compared with the negative control group and blank control group, qRT-PCR showed that the expression level of miR-19a was significantly reduced after transfection (F = 124.72, P < 0.01). CCK-8 revealed that proliferation ability of miR-19a inhibitor group was significantly suppressed. The cell survival rate in miR-19a inhibitor group after 48 h was (48.27±8.23) %, compared with the blank control group(100.00 %), the difference was statistically significant (t = 12.45, P < 0.01). After low-expression of miR-19a, the G0/G1 phase cells were increased and S phase cells were decreased. The low-expression of miR-19a could induce cell apoptosis. Conclusions Low-expression of miR-19a can inhibit cell proliferation, block G1/S transition and induce apoptosis in human glioma cell line U251. miR-19a may serve as an attractive target of gene therapy for glioblastoma. Key words: miR-19a; Human glioma; Cell proliferation; Apoptosis

About this research paper

What this paper is about

Objective To investigate the effect of knocking down miR -19a on proliferation and apoptosis of human glioma cell line U251 in vitro. Methods U251 cells were cultured routinely. MiR-19a inhibitor was transfected into U251 cells by Lipofectamine 2000. At the same time, the negative control group and blank control group were established. The expression level of miR-19a was detected by RT-PCR. and cell proliferation was analyzed by CCK-8 assay. The changes of cell apoptosis and cycle were monitored by flow cytometry. Results Compared with the negative control group and blank control group, qRT-PCR showed that the expression level of miR-19a was significantly reduced after transfection (F = 124.72, P < 0.01). CCK-8 revealed that proliferation ability of miR-19a inhibitor group was significantly suppressed. The cell survival rate in miR-19a inhibitor group after 48 h was (48.27±8.23) %, compared with the blank control group(100.00 %), the difference was statistically significant (t = 12.45, P < 0.01). After low-expression of miR-19a, the G0/G1 phase cells were increased and S phase cells were decreased. The low-expression of miR-19a could induce cell apoptosis. Conclusions Low-expression of miR-19a can inhibit cell proliferation, block G1/S transition and induce apoptosis in human glioma cell line U251. miR-19a may serve as an attractive target of gene therapy for glioblastoma. Key words: miR-19a; Human glioma; Cell proliferation; Apoptosis

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of knocking down miR -19a on proliferation and apoptosis of human glioma cell line U251 in vitro. Methods U251 cells were cultured routinely. MiR-19a inhibitor was transfected into U251 cells by Lipofectamine 2000. At the same time, the negative control group and blank control group were established. The expression level of miR-19a was detected by RT-PCR. and cell proliferation was analyzed by CCK-8 assay. The changes of cell apoptosis and cycle were monitored by flow cytometry. Results Compared with the negative control group and blank control group, qRT-PCR showed that the expression level of miR-19a was significantly reduced after transfection (F = 124.72, P < 0.01). CCK-8 revealed that proliferation ability of miR-19a inhibitor group was significantly suppressed. The cell survival rate in miR-19a inhibitor group after 48 h was (48.27±8.23) %, compared with the blank control group(100.00 %), the difference was statistically significant (t = 12.45, P < 0.01). After low-expression of miR-19a, the G0/G1 phase cells were increased and S phase cells were decreased. The low-expression of miR-19a could induce cell apoptosis. Conclusions Low-expression of miR-19a can inhibit cell proliferation, block G1/S transition and induce apoptosis in human glioma cell line U251. miR-19a may serve as an attractive target of gene therapy for glioblastoma. Key words: miR-19a; Human glioma; Cell proliferation; Apoptosis

Key concepts: Apoptosis, Lipofectamine, Transfection, Cell growth, Glioma, Cell cycle, Flow cytometry, Cell culture

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of knocking down miR-19a on proliferation and apoptosis of human glioma cell line U251 in vitro — Research Paper | ScholarLens